---
figid: PMC7800773__oncotarget-12-10-g001
figtitle: Combination therapies for MPNSTs targeting RABL6A-RB1 signaling
organisms:
- NA
organisms_ner:
- Danio rerio
- Homo sapiens
pmcid: PMC7800773
filename: oncotarget-12-10-g001.jpg
figlink: pmc/articles/PMC7800773/figure/F1/
number: F1
caption: The central regulators of the RB1 tumor suppressor are highlighted in the
  gray box. Representative inhibitors of the indicated kinases are depicted in red.
  RABL6A inhibits RB1 by reducing the CDK inhibitor, p27, and activating MEK and Myc.
  Arrows, activating events; perpendicular bars, inhibitory events.
papertitle: Combination therapies for MPNSTs targeting RABL6A-RB1 signaling.
reftext: Jordan L. Kohlmeyer, et al. Oncotarget. 2021 Jan 5;12(1):10-14.
year: '2021'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9140419
figid_alias: PMC7800773__F1
figtype: Figure
redirect_from: /figures/PMC7800773__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7800773__oncotarget-12-10-g001.html
  '@type': Dataset
  description: The central regulators of the RB1 tumor suppressor are highlighted
    in the gray box. Representative inhibitors of the indicated kinases are depicted
    in red. RABL6A inhibits RB1 by reducing the CDK inhibitor, p27, and activating
    MEK and Myc. Arrows, activating events; perpendicular bars, inhibitory events.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - rab1ab
  - rabl6a
  - cdk2
  - cdk6
  - cdk4
  - rb1
  - KRAS
  - HRAS
  - NRAS
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - IFI27
  - PSMD9
  - ZNRD2
  - DCTN6
  - TMED7
  - H3P23
  - CDK2
  - CCNE1
  - CCNE2
  - CCND1
  - CCND2
  - CCND3
  - CDK6
  - CDK4
  - RB1
  - RBM45
  - ASPRV1
  - Mirdametinib
  - Selumetinib
  - Trametinib
  - Binimetinib
---
